Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.36
Bid: 17.52
Ask: 18.48
Change: -0.23 (-1.31%)
Spread: 0.96 (5.479%)
Open: 17.98
High: 18.00
Low: 17.36
Prev. Close: 17.59
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Runcorn Commissioning

27 Jan 2011 15:00

RNS Number : 2114A
Nanoco Group PLC
27 January 2011
 



For immediate release

27 January 2011

 

 

NANOCO GROUP PLC

("Nanoco" or "the Company")

 

Commissioning of Production Lines

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots, announces the successful commissioning of the production lines at its new facility in Runcorn, Cheshire.

 

The Runcorn facility - the Company's first commercial production capability - comprises 3000 square feet of laboratory and administrative space at The Heath Technology Park. It includes two dedicated Semi-Tech production lines, which together are expected, initially, to have the capacity to produce around 25kg of cadmium-free quantum dots (CFQDTM) annually.

 

Commercial-scale batches of high quality red CFQDTM have been successfully manufactured during commissioning. Nanoco is now trialling batches for a specific customer application and expects to be able to deliver 1kg of red CFQDTM to the customer within the next few months. Once validated by the customer, this will, subject to the Company's satisfaction of certain other contractual terms and conditions, trigger a $2m milestone payment. The Company also anticipates shipping 1kg of green CFQDTM in mid 2011, subject to similar terms and conditions.

 

The commissioning at the Runcorn site is a key step in the Company's multi-stage strategic plan for scaling up manufacturing capacity to meet anticipated demand in lighting, display, solar and other growth markets.

 

Michael Edelman, Nanoco's Chief Executive Officer, said: "Manufacturing in-house is central to Nanoco's business model and therefore the commissioning of the Runcorn facility marks an important milestone for the Company. The facility represents the Company's first commercial production capability and we now look forward to manufacturing significant volumes of quantum dots for our customers."

 

 

For further information please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Colin White, Chief Financial Officer

Bank of America Merrill Lynch - Corporate Broker

Tel: + 44 (0) 20 7996 2490

Will Smith

Zeus Capital - Nominated Adviser

Tel: +44 (0) 161 831 1512

Alex Clarkson

Nick Cowles

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Mark Court / Christian Goodbody

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including lighting, solar cells and biological imaging. Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass. Nanoco forms strategic partnerships with major end users across a range of applications.

Nanoco was founded in 2001 and is based in Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.

For further information, please visit www.nanocotechnologies.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGZMDNRGMZM
Date   Source Headline
6th Sep 20194:35 pmRNSPrice Monitoring Extension
5th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Sep 20191:00 pmRNSNotice of Results
22nd Aug 20192:00 pmRNSHolding(s) in Company
15th Aug 20197:00 amRNSYear End Trading Update and Notice of Results
1st Aug 20196:15 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSContract Liability Waived
3rd Jul 20195:50 pmRNSHolding(s) in Company
27th Jun 201912:15 pmRNSHolding(s) in Company
26th Jun 20193:20 pmRNSDirector/PDMR Shareholding
26th Jun 201911:45 amRNSHolding(s) in Company
25th Jun 201912:45 pmRNSHolding(s) in Company
24th Jun 20193:45 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
21st Jun 20197:00 amRNSUS Customer partnership update
12th Jun 201910:25 amRNSBlock listing Interim Review
7th Jun 20194:00 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSDirector/PDMR Shareholding
2nd May 20196:09 pmRNSDirector/PDMR Shareholding
18th Apr 20194:55 pmRNSDirector/PDMR Shareholding
17th Apr 20193:20 pmRNSHolding(s) in Company
17th Apr 20191:22 pmRNSHolding(s) in Company
16th Apr 20195:08 pmRNSHolding(s) in Company
11th Apr 20193:38 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSInterim Results
1st Apr 201911:40 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSDirectorate Changes
4th Mar 20197:00 amRNSNotice of Results
31st Jan 20197:00 amRNSChange of Auditor
25th Jan 20197:00 amRNSContract extension signed
4th Jan 201912:18 pmRNSHolding(s) in Company
4th Jan 20197:00 amRNSPartnership with Plessey Semiconductors
24th Dec 20187:00 amRNSMilestone Achieved
13th Dec 20183:33 pmRNSResult of AGM
13th Dec 20187:00 amRNSAGM Statement
10th Dec 20184:00 pmRNSBLOCKLISTING SIX-MONTHLY RETURN
3rd Dec 201811:18 amRNSDirector Declaration
3rd Dec 20187:00 amRNSHolding(s) in Company
30th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20184:53 pmRNSHolding(s) in Company
15th Nov 20187:00 amRNSDirector/PDMR Shareholding
13th Nov 20188:15 amRNSAnnual Report and Notice of AGM
7th Nov 20181:33 pmRNSDirector/PDMR Shareholding
24th Oct 20187:00 amRNSHolding(s) in Company
17th Oct 20181:47 pmRNSDirector/PDMR Shareholding
16th Oct 201811:14 amRNSDirector/PDMR Shareholding
16th Oct 20187:00 amRNSPreliminary Results
3rd Oct 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.